Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR-enzyme immunoassay in population-based cervical screening.
about
Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening.Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study.The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia.Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR.The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening.The cytology and DNA detection by the PapilloCheck(®) test in the diagnosis of human papillomavirus infection.The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screeningClinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.Commercially available assays for multiplex detection of alpha human papillomaviruses.Cervical cancer screening: on the way to a shift from cytology to full molecular screening.Predictors of abnormal cytology among HPV-infected women in remote territories of French Guiana.Human papillomavirus type distribution in vulval intraepithelial neoplasia determined using PapilloCheck DNA Microarray.
P2860
Q35066533-A4262837-0361-451E-B2C2-FB043FE1C7D1Q35342179-A4663987-6D19-43C6-B968-30F680434788Q36173887-FB8F2A13-7D7E-413E-A057-2B1560D4F67FQ37132091-3610625D-9E35-440F-B44E-A3F2C7DC6294Q37218627-2D2215DA-249E-410D-A458-E0351BECF611Q37319972-FF94497F-16D6-4731-8F25-5D80ED2A1C88Q37470374-F665F724-0F05-4FE8-86CA-BED0DEB39CCCQ37643509-418ED4F5-54D2-4704-BEE5-94EEBB65A6D2Q37800921-325AE033-288A-4526-B84C-20633216FA17Q38180277-636D7D19-6702-48D6-B572-9BD05AB331F5Q47549030-8F2F0D9C-19EC-4435-B2DF-36990D76D6D3Q51548591-E49806E2-1B34-4711-835E-1558AB66D01A
P2860
Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR-enzyme immunoassay in population-based cervical screening.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Comparison of the clinical per ...... tion-based cervical screening.
@ast
Comparison of the clinical per ...... tion-based cervical screening.
@en
type
label
Comparison of the clinical per ...... tion-based cervical screening.
@ast
Comparison of the clinical per ...... tion-based cervical screening.
@en
prefLabel
Comparison of the clinical per ...... tion-based cervical screening.
@ast
Comparison of the clinical per ...... tion-based cervical screening.
@en
P2093
P2860
P356
P1476
Comparison of the clinical per ...... tion-based cervical screening.
@en
P2093
A T Hesselink
C J L M Meijer
D A M Heideman
P J F Snijders
P2860
P304
P356
10.1128/JCM.01743-09
P407
P577
2009-12-30T00:00:00Z